256 related articles for article (PubMed ID: 32676358)
21. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis.
Cury PM; Butcher DN; Corrin B; Nicholson AG
J Pathol; 1999 Oct; 189(2):251-7. PubMed ID: 10547583
[TBL] [Abstract][Full Text] [Related]
22. The immunohistochemical profile of malignant mesotheliomas of the tunica vaginalis: a study of 20 cases.
Winstanley AM; Landon G; Berney D; Minhas S; Fisher C; Parkinson MC
Am J Surg Pathol; 2006 Jan; 30(1):1-6. PubMed ID: 16330935
[TBL] [Abstract][Full Text] [Related]
23. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma.
Sterman DH; Albelda SM
Respirology; 2005 Jun; 10(3):266-83. PubMed ID: 15955137
[TBL] [Abstract][Full Text] [Related]
24. Localized biphasic type malignant mesothelioma arising in the peritoneum: Report of a case.
Kohno M; Maruyama R; Kitagawa D; Sugimachi K; Kinjo M; Higashi H
Thorac Cancer; 2014 Jan; 5(1):74-7. PubMed ID: 26766976
[TBL] [Abstract][Full Text] [Related]
25. Malignant Mesothelioma Diagnosis.
Arif Q; Husain AN
Arch Pathol Lab Med; 2015 Aug; 139(8):978-80. PubMed ID: 26230591
[TBL] [Abstract][Full Text] [Related]
26. Malignant Mesothelioma - Report of Two Cases with Different Presentations.
Munot MN; Utpat KV; Desai UD; Joshi JM
Indian J Occup Environ Med; 2019; 23(2):93-96. PubMed ID: 31619883
[TBL] [Abstract][Full Text] [Related]
27. Three newly established immortalized mesothelial cell lines exhibit morphological phenotypes corresponding to malignant mesothelioma epithelioid, intermediate, and sarcomatoid types, respectively.
Sato T; Nakanishi H; Akao K; Okuda M; Mukai S; Kiyono T; Sekido Y
Cancer Cell Int; 2021 Oct; 21(1):546. PubMed ID: 34663305
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Nuclear Grade, Necrosis, and Histologic Subtype Between Biopsy and Resection in Pleural Malignant Mesothelioma: An International Multi-Institutional Analysis.
Schulte JJ; Chapel DB; Attanoos R; Brcic L; Burn J; Butnor KJ; Chang N; Chen H; Dacic S; De Perrot M; Fukuoka J; Galateau-Salle F; Godschachner T; Hiroshima K; Klebe S; Krausz T; Litzky L; Marchevsky AM; Mueller J; Nabeshima K; Nicholson AG; Pal P; Roden AC; Rorvig S; Santoni-Rugiu E; Tazelaar H; Tsao MS; Walts AE; Weynand B; Zaizen Y; Zhang YZ; Husain AN
Am J Clin Pathol; 2021 Nov; 156(6):989-999. PubMed ID: 33978147
[TBL] [Abstract][Full Text] [Related]
29. KRAS Mutations Are Associated with Shortened Survival in Patients with Epithelioid Malignant Pleural Mesothelioma.
Vannucchi M; Pennati V; Mencaroni C; Defraia C; Bardhi L; Castiglione F; Bellan C; Comin CE
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046732
[TBL] [Abstract][Full Text] [Related]
30. Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions.
Lagana SM; Taub RN; Borczuk AC
Arch Pathol Lab Med; 2012 Jul; 136(7):804-9. PubMed ID: 22742553
[TBL] [Abstract][Full Text] [Related]
31. Validation of a Gene Expression Approach for the Cytological Diagnosis of Epithelioid and Biphasic Pleural Mesothelioma on a Consecutive Series.
Bruno R; Poma AM; Alì G; Proietti A; Ribechini A; Chella A; Fontanini G
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067238
[TBL] [Abstract][Full Text] [Related]
32. Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma.
Bueno R; Reblando J; Glickman J; Jaklitsch MT; Lukanich JM; Sugarbaker DJ
Ann Thorac Surg; 2004 Nov; 78(5):1774-6. PubMed ID: 15511473
[TBL] [Abstract][Full Text] [Related]
33. Malignant mesothelioma of the tunica vaginalis testis: diagnostic studies and differential diagnosis.
Chekol SS; Sun CC
Arch Pathol Lab Med; 2012 Jan; 136(1):113-7. PubMed ID: 22208496
[TBL] [Abstract][Full Text] [Related]
34. Well-differentiated papillary mesothelioma occurring in the tunica vaginalis of the testis with contralateral atypical mesothelial hyperplasia.
Tolhurst SR; Lotan T; Rapp DE; Lyon MB; Orvieto MA; Gerber GS; Sokoloff MH
Urol Oncol; 2006; 24(1):36-9. PubMed ID: 16414491
[TBL] [Abstract][Full Text] [Related]
35. Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases.
Malpica A; Sant'Ambrogio S; Deavers MT; Silva EG
Am J Surg Pathol; 2012 Jan; 36(1):117-27. PubMed ID: 22024662
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma.
Hiraki A; Aoe K; Murakami T; Nakamura Y; Yamazaki K; Sueoka N; Taguchi K; Kamei T; Maeda T; Takeyama H; Kishimoto T; Nishimura M; Sugi K
Oncol Rep; 2005 Aug; 14(2):357-62. PubMed ID: 16012715
[TBL] [Abstract][Full Text] [Related]
37. Malignant mesothelioma.
Ahmed I; Ahmed Tipu S; Ishtiaq S
Pak J Med Sci; 2013 Nov; 29(6):1433-8. PubMed ID: 24550969
[TBL] [Abstract][Full Text] [Related]
38. [Clinicopathological characteristics and prognosis of malignant pleural mesothelioma].
Chen WH; Zhang XL; Dai HP; Tong ZH; Zhang YH; Jin ML
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):825-8. PubMed ID: 24507393
[TBL] [Abstract][Full Text] [Related]
39. [Pleuro-pulmonary metastases from a malignant mesothelioma of the tunica vaginalis].
Pannier D; Caty A; Hysi I; Bouchindhomme B; Copin MC; Porte H; Dansin E
Rev Mal Respir; 2011 Nov; 28(9):1155-7. PubMed ID: 22123142
[TBL] [Abstract][Full Text] [Related]
40. Concomitant malignant mesothelioma of the pleura, peritoneum, and tunica vaginalis testis.
Ascoli V; Facciolo F; Rahimi S; Scalzo CC; Nardi F
Diagn Cytopathol; 1996 May; 14(3):243-8. PubMed ID: 8732655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
